Evidence map›Paper›PMID 39964317›Full record

ArticleAIDS (London, England)2025

Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets.

Marieke M Nühn, Kobus Bosman, Terry Huisman, Wouter H A Staring, Lavina Gharu, Dorien De Jong, Theun M De Kort, Ninée V E J Buchholtz, Kiki Tesselaar, Aridaman Pandit and 9 more

Abstract read
In one paragraph

Article in AIDS (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marieke M NühnTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.
Kobus BosmanTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.
Terry HuismanTheoretical Biology, Utrecht University.
Wouter H A StaringDepartment of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen.
Lavina GharuTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.
Dorien De JongTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.
Theun M De KortTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.
Ninée V E J BuchholtzTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.
Kiki TesselaarCenter for Translational Immunology, University Medical Center Utrecht, Utrecht.
Aridaman PanditTheoretical Biology, Utrecht University.
Joop ArendsFaculty of Health, Medicine and Life Sciences, Maastricht UMC (MUMC), Maastricht.
Sigrid A OttoCenter for Translational Immunology, University Medical Center Utrecht, Utrecht.
Eduardo Lucio De EsesarteTheoretical Biology, Utrecht University.
Andy I M HoepelmanDepartment of Internal Medicine and Infectious Diseases, University Medical Center Utrecht.
Rob J De BoerTheoretical Biology, Utrecht University.
Jori SymonsTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.
José A M BorghansCenter for Translational Immunology, University Medical Center Utrecht, Utrecht.
Annemarie M J WensingTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.
Monique NijhuisTranslational Virology, Department of Medical Microbiology, University Medical Center Utrecht.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the short- and long-term dynamics of intact and defective proviral HIV DNA during ART.

designWe evaluated viral reservoir dynamics in a cohort of nine individuals with chronic HIV-1 subtype B who initiated first-line ART and were followed for 20 years while continuing ART.

methodsPBMCs were obtained before ART ( n  = 5), during the first year, and after 8.5 and 20 years of treatment. T cell subsets (naive, central-memory, transitional-memory and effector-memory) were sorted at 8.5 and 20 years. DNA was isolated and analyzed using the intact proviral DNA assay (IPDA). Deep-sequencing of the viral env region enabled analysis of viral evolution and cellular mechanisms underlying HIV persistence.

resultsInitially, defective and intact proviral DNA in PBMCs declined with half-lives of 3.6 and 5.4 weeks, respectively. Over the following 8.5 years, the intact reservoir continued to decrease, with a half-life of 18.8 months in PBMCs, while defective proviral DNA levels stabilized. After 8.5 and 20 years of ART, the intact reservoir showed no further decline, with most intact proviral DNA residing in memory T cell subsets. Phylogenetic analysis revealed no signs of viral evolution over time, both within and between T cell subsets.

conclusionsPBMCs containing intact proviral DNA are selectively lost during the first decade of suppressive ART, followed by a decade of stabilization of this reservoir in the memory T cell subsets. In the absence of clear signs of viral evolution and massive clonal expansion, homeostatic proliferation might be an important driver of HIV persistence during long-term ART.

Indexed as

Anti-Retroviral AgentsHIV-1HIV InfectionsMemory T CellsT-Lymphocyte SubsetsAdultDNA, ViralFemaleHigh-Throughput Nucleotide SequencingHumansLeukocytes, MononuclearMaleMiddle AgedProvirusesSequence Analysis, DNATime FactorsAnti-Retroviral AgentsDNA, Viralantiretroviral therapydefectiveHIVintactpersistencereservoir dynamicsT cell subsets

Identifiers

PMID39964317
PMCPMC12077340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.